Atlas Trials

Parameters of Acceptability, Compliance and Efficacy of Fulvestrant in Post-menopausal Patients With Advance Breast Cancer

Clinical trial NCT00878930 · COMPLETED

Trial details

NCT number
NCT00878930
Sponsor
AstraZeneca
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2009-04-01
Primary completion
2010-12-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.